Cargando…

Targeting transcriptional regulators to regenerate midbrain dopaminergic axons in Parkinson's disease

Detalles Bibliográficos
Autores principales:	Hegarty, Shane V., Sullivan, Aideen M., O’Keeffe, Gerard W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2017
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5745834/ https://www.ncbi.nlm.nih.gov/pubmed/29239326 http://dx.doi.org/10.4103/1673-5374.219039

Ejemplares similares

Targeting bone morphogenetic protein signalling in midbrain dopaminergic neurons as a therapeutic approach in Parkinson's disease
por: O'Keeffe, Gerard W., et al.
Publicado: (2017)

Zeb2 is a negative regulator of midbrain dopaminergic axon growth and target innervation
por: Hegarty, Shane V., et al.
Publicado: (2017)

Protocol for evaluation of neurotrophic strategies in Parkinson’s disease-related dopaminergic and sympathetic neurons in vitro
por: Hegarty, Shane V., et al.
Publicado: (2016)

Inhibition of miR-181a promotes midbrain neuronal growth through a Smad1/5-dependent mechanism: implications for Parkinson’s disease
por: Hegarty, Shane V., et al.
Publicado: (2018)

The Epigenome as a therapeutic target for Parkinson's disease
por: Hegarty, Shane V., et al.
Publicado: (2016)

Neurotrophic factors: from neurodevelopmental regulators to novel therapies for Parkinson's disease
por: Hegarty, Shane V., et al.
Publicado: (2014)

Editorial: The Role of Stem Cells, Epigenetics and MicroRNAs in Parkinson's Disease
por: Hegarty, Shane V., et al.
Publicado: (2020)

Neurotrophic factor therapy for Parkinson's disease: past, present and future
por: Sullivan, Aideen M., et al.
Publicado: (2016)

The class II histone deacetylases as therapeutic targets for Parkinson’s disease
por: Mazzocchi, Martina, et al.
Publicado: (2020)

Transforming growth factor β1-mediated anti-inflammation slows progression of midbrain dopaminergic neurodegeneration in Parkinson's disease?
por: Spittau, Björn
Publicado: (2015)

Wnt5a Regulates Midbrain Dopaminergic Axon Growth and Guidance
por: Blakely, Brette D., et al.
Publicado: (2011)

Sonic Hedgehog Is a Chemoattractant for Midbrain Dopaminergic Axons
por: Hammond, Rachel, et al.
Publicado: (2009)

Diet quality, sleep and quality of life in Parkinson’s disease: a cross-sectional study
por: Dunk, Danielle, et al.
Publicado: (2022)

The dietary flavonoid isoliquiritigenin is a potent cytotoxin for human neuroblastoma cells
por: Alshangiti, Amnah M., et al.
Publicado: (2019)

The neuroprotective and regenerative potential of parkin and GDNF/Ret signaling in the midbrain dopaminergic system
por: Kramer, Edgar R.
Publicado: (2015)

Gene Co-expression Analysis Identifies Histone Deacetylase 5 and 9 Expression in Midbrain Dopamine Neurons and as Regulators of Neurite Growth via Bone Morphogenetic Protein Signaling
por: Mazzocchi, Martina, et al.
Publicado: (2019)

The potential of bone morphogenetic protein 2 as a neurotrophic factor for Parkinson's disease
por: Goulding, Susan R., et al.
Publicado: (2020)

Transplantation of novel human GDF5-expressing CHO cells is neuroprotective in models of Parkinson's disease
por: Costello, Daniel J, et al.
Publicado: (2012)

Genetically modifying transcription factors to promote CNS axon regeneration
por: Mehta, Saloni T., et al.
Publicado: (2017)

Acetylation as a mechanism that regulates axonal regeneration
por: Lin, Shen, et al.
Publicado: (2015)

4-Hydroxychalcone Induces Cell Death via Oxidative Stress in MYCN-Amplified Human Neuroblastoma Cells
por: Alshangiti, Amnah M., et al.
Publicado: (2019)

Ascending midbrain dopaminergic axons require descending GAD65 axon fascicles for normal pathfinding
por: García-Peña, Claudia M., et al.
Publicado: (2014)

Growth differentiation factor 5: a neurotrophic factor with neuroprotective potential in Parkinson’s disease
por: Goulding, Susan R., et al.
Publicado: (2021)

Diverse midbrain dopaminergic neuron subtypes and implications for complex clinical symptoms of Parkinson’s disease
por: Carmichael, Kathleen, et al.
Publicado: (2021)

Protein deacetylases and axonal regeneration
por: Ng, Fanny, et al.
Publicado: (2015)

Cognitive Functional Therapy: An Integrated Behavioral Approach for the Targeted Management of Disabling Low Back Pain
por: O’Sullivan, Peter B, et al.
Publicado: (2018)

Biophysical Properties of Somatic and Axonal Voltage-Gated Sodium Channels in Midbrain Dopaminergic Neurons
por: Yang, Jun, et al.
Publicado: (2019)

Association of distinct type 1 bone morphogenetic protein receptors with different molecular pathways and survival outcomes in neuroblastoma
por: Alshangiti, Amnah M., et al.
Publicado: (2020)

RAFting the rapids of axon regeneration signaling
por: Zhong, Jian
Publicado: (2015)

Casein kinase signaling in axon regeneration
por: Ayad, Nagi G., et al.
Publicado: (2016)

Axon regeneration: membrane expansion and lipidomics
por: Meehan, Sean, et al.
Publicado: (2021)

Transcriptional comparison of human induced and primary midbrain dopaminergic neurons
por: Xia, Ninuo, et al.
Publicado: (2016)

Morpholino studies shed light on the signaling pathways regulating axon regeneration in lampreys
por: Sobrido-Cameán, Daniel, et al.
Publicado: (2021)

Pathological characteristics of axons and proteome patterns in midbrain dopaminergic neurodegeneration induced by WDR45-deficiency
por: Le, Weidong, et al.
Publicado: (2023)

Microfluidic systems for axonal growth and regeneration research
por: Kim, Sunja, et al.
Publicado: (2014)

76nt RNAs are transported axonally into regenerating axons and growth cones. What are they doing there?
por: Ingoglia, Nicholas A., et al.
Publicado: (2016)

Reassembly of the axon initial segment and nodes of Ranvier in regenerated axons of the central nervous system
por: Marin, Miguel A., et al.
Publicado: (2017)

The immunogenicity of midbrain dopaminergic neurons and the implications for neural grafting trials in Parkinson’s disease
por: Qarin, Shamma, et al.
Publicado: (2021)

Glycogen synthase kinase 3: a crucial regulator of axotomy-induced axon regeneration
por: Liu, Jinlian, et al.
Publicado: (2019)

Acquisition of the Midbrain Dopaminergic Neuronal Identity
por: Mesman, Simone, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_on39a5lh3ib0p1qtpqe85r3t6b